The molecular structure of MariTide involves coupling two GLP-1 receptor agonist peptides to an antibody against GIP (Glucose-dependent Insulinotropic Peptide, also known as incretin), forming a three-part conjugate of antibody-peptide conjugate
In the case of Mounjaro after 11 months on the market, transitional assistance accounts for a quarter of all commercial new starts and more than half of all commercial claims as continuing patients become repeat beneficiaries of transitional assistance
Dry Mouth (Xerostomia): Many medications, including some GLP-1 agonists, can reduce saliva production
doi: 10.3390/cancers16010155 95 BottoniLMinettiARealiniGPioEGiustariniDRossiRet al
This unique NSAID-antagonizing effect presents a significant potential clinical application for patients requiring long-term NSAID therapy
D1 S3:Recombinant Peptide Production and Host Cell Impurities Format: Presentations and a Panel Discussion with Q&A (Virtual and In-Person Attendees) This session examines best practices for controlling host cell impurities in recombinant peptide production, drawing on regulatory expectations and experience from 505(b)(2) applications and biologics (including insulins)